UNSW research into childhood cancer and treatments for patients with nerve damage has received major backing in the latest round of funding from The Cancer Institute NSW.
Children fighting a life-threatening form of cancer could be treated with a revolutionary anti-cancer therapy as early as next year, following the formation of a research alliance to fast-track development of a drug pioneered by UNSW researchers.
The unique partnership between Professor Peter Gunning and The Kids’ Cancer Project is leading to a new treatment for children fighting childhood cancer, as featured on ABC TV’s Australian Story. VIDEO
While survival rates for childhood cancers are increasing, researchers are concerned most survivors are not returning for necessary, long-term follow up care.
In a world-first, UNSW researchers have developed a nanoparticle that could improve the effectiveness of chemotherapy for neuroblastoma by a factor of five.
The medical research community can only be encouraged by the level of commitment demonstrated by the NSW government's $30 million funding to fast track cancer research, UNSW's Dean of Medicine, Professor Peter Smith, says.
Three world-first clinical trials to tackle one of the most common and aggressive childhood cancers have been backed by $6 million in federal government funding.
